Resources
Cision June 18, 2024 Read the full press release >> Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE) insights generation, deep specialty data, and advanced AI healthcare technologies. This latest offering enables Panalgo to host OM1’s PremiOM enriched[…]
Dermatology Times February 20, 2024 Read the full article >> “Rare Disease Day raises awareness for the 300 million people living with rare diseases around the world and their families and carers. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis and [delayed] treatment,” writes the Rare Disease Day organization.1 Rare Disease Day has[…]
Dermatology Times December 15, 2023 Stefan Weiss, MD, MBA, FAAD Read the full article >> 2023 brought exciting advances in the treatment of alopecia areata and vitiligo, autoimmune skin conditions that can significantly impact a person’s physical appearance and emotional well-being. The emergence of Janus kinase (JAK) inhibitors has shown tremendous promise as a novel[…]
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
HIT Consultant October 3, 2023 Read the full article >> What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient[…]
